Artificial bone material
Vietnam·Risk Class TTBYT Loại D·Theo theo phụ lục·CG Bio Co., Ltd.·Registered Aug 27, 2024- Analysis ID
- 2402170ĐKLH/BYT-HTTB
- Submission ID
- 18007097/ĐKLH-BYT-TB-CT
- Product Type
- Theo theo phụ lục
- Product Code
- Theo phụ lục
- Manufacturer
- CG Bio Co., Ltd.
- Manufacturer Country
- Theo theo phụ lục
- Product Owner
- CG Bio Co., Ltd.
- Authorized Representative
- VĂN PHÒNG ĐẠI DIỆN DAEWOONG PHARMACEUTICAL CO., LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH
- Intended Use
- Novosis is indicated for bone defects or deficiencies that are not related to the stability of the bone structure. Novosis is indicated to gradually fill bone defects or deficiencies in the skeletal system (such as in the limbs, spine, pelvis, etc.). These bone defects can be caused by surgical procedures or bone damage. The product provides material to fill the bone defects, which is gradually reabsorbed and replaced by bone during the healing process.
- Registration Date
- Aug 27, 2024
Companies providing products similar to "Artificial bone material"
Recently registered similar products
Access comprehensive regulatory information for Artificial bone material in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402170ĐKLH/BYT-HTTB and manufactured by CG Bio Co., Ltd.. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN DAEWOONG PHARMACEUTICAL CO., LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.
This page provides complete technical specifications, regulatory compliance details, 4 companies making similar products including RTI Surgical, Inc, Geistlich Pharma AG , and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.